Navigation path

Community Register of medicinal products

Community register of orphan medicinal products


GRANTED  

Product information

Carbetocin

EU orphan designation number: EU/3/12/975   
Active ingredient: Carbetocin
Indication: Treatment of Prader-Willi syndrome
Sponsor: Ferring Pharmaceuticals A/S
Kay Fiskers Plads 11, DK-2300 København S, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/03/2012 Centralised Orphan - Designation EMA/OD/119/11 (2012)2018 of 21/03/2012